Combination avelumab and utomilumab immunotherapy can induce diabetic ketoacidosis

被引：10

作者：

Atkins, P. W. ^{[1
]}

Thompson, D. M. ^{[1
]}

机构：

[1] Univ British Columbia, Div Endocrinol, Dept Med, Vancouver, BC, Canada

来源：

DIABETES & METABOLISM | 2018年 / 44卷 / 06期

关键词：

D O I：

10.1016/j.diabet.2017.05.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：514 / 515

页数：3

共 10 条

[1] The PD1:PD-L1/2 Pathway from Discovery to Clinical implementation [J].

Bardhan, Kankana ;

Anagnostou, Theodora ;

Boussiotis, Vassiliki A. .

FRONTIERS IN IMMUNOLOGY, 2016, 7

[2] 4-1 BB agonists: multi-potent potentiators of tumor immunity [J].

Bartkowiak, Todd ;

Curran, Michael A. .

FRONTIERS IN ONCOLOGY, 2015, 5

[3] 4-1BB agonism: adding the accelerator to cancer immunotherapy [J].

Chester, Cariad ;

Ambulkar, Siddhant ;

Kohrt, Holbrook E. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (10) :1243-1248

[4]

Food U. S. Drug Administration, 2017, BAVENCIO AV PRESCR I

[5]

Food U. S. Drug Administration, 2015, YERVOY IP PRESCR INF

[6]

Food U. S. Drug Administration, 2016, OPDIVO NIV PRESCR IN

[7] Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer [J].

Liu, Jing ;

Blake, Stephen J. ;

Harjunpaa, Heidi ;

Fairfax, Kirsten A. ;

Yong, Michelle C. R. ;

Allen, Stacey ;

Kohrt, Holbrook E. ;

Takeda, Kazuyoshi ;

Smyth, Mark J. ;

Teng, Michele W. L. .

CANCER RESEARCH, 2016, 76 (18) :5288-5301

[8] Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy [J].

Lowe, Jared R. ;

Perry, Daniel J. ;

Salama, April K. S. ;

Mathews, Clayton E. ;

Moss, Larry G. ;

Hanks, Brent A. .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4

[9] Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies (vol 26, pg 2375, 2015) [J].

Naidoo, J. ;

Page, D. B. ;

Li, B. T. ;

Connell, L. C. ;

Schindler, K. ;

Lacouture, M. E. ;

Postow, M. A. ;

Wolchok, J. D. .

ANNALS OF ONCOLOGY, 2016, 27 (07) :1362-1362

[10] Fulminant type1 diabetes mellitus with anti-programmed cell death-1 therapy [J].

Okamoto, Masahide ;

Okamoto, Mitsuhiro ;

Gotoh, Koro ;

Masaki, Takayuki ;

Ozeki, Yoshinori ;

Ando, Hisae ;

Anai, Manabu ;

Sato, Asami ;

Yoshida, Yuichi ;

Ueda, So ;

Kakuma, Tetsuya ;

Shibata, Hirotaka .

JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (06) :915-918

← 1 →